Arcadia Biosciences, Inc. (NASDAQ:RKDA – Get Free Report) was the recipient of a significant growth in short interest in the month of February. As of February 15th, there was short interest totalling 15,000 shares, a growth of 102.7% from the January 31st total of 7,400 shares. Based on an average daily trading volume, of 1,150,000 shares, the short-interest ratio is presently 0.0 days. Currently, 1.1% of the shares of the company are short sold.
Hedge Funds Weigh In On Arcadia Biosciences
An institutional investor recently bought a new position in Arcadia Biosciences stock. Geode Capital Management LLC bought a new position in shares of Arcadia Biosciences, Inc. (NASDAQ:RKDA – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 12,297 shares of the basic materials company’s stock, valued at approximately $73,000. Geode Capital Management LLC owned 0.90% of Arcadia Biosciences at the end of the most recent quarter. 17.73% of the stock is currently owned by institutional investors.
Arcadia Biosciences Stock Performance
Shares of NASDAQ RKDA traded up $0.05 during trading hours on Friday, reaching $3.91. 5,148 shares of the stock were exchanged, compared to its average volume of 11,476. The firm has a market capitalization of $5.34 million, a price-to-earnings ratio of -0.91 and a beta of 0.88. Arcadia Biosciences has a 52 week low of $1.85 and a 52 week high of $10.31. The stock’s fifty day simple moving average is $5.05 and its 200 day simple moving average is $4.04.
Analyst Upgrades and Downgrades
Check Out Our Latest Analysis on RKDA
Arcadia Biosciences Company Profile
Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.
Recommended Stories
- Five stocks we like better than Arcadia Biosciences
- Profitably Trade Stocks at 52-Week Highs
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- The Basics of Support and Resistance
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
- What Are Trending Stocks? Trending Stocks Explained
- MarketBeat Week in Review – 02/24 – 02/28
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.